RED1: NICE TA611 - for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer. (Decision date - December 2019)
Red Drug Classifications
1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
8. NHS England commissioned – to be used in line with NHSE commissioning intentions
